Gossamer Bio GOSS
NASDAQ GOSS
$9.60 +0.14 (+1.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Other Accumulated Expenses (2018 - 2020)

Updated

Gossamer Bio (GOSS) recorded Other Accumulated Expenses of $1.34 million in Q2 2020, up 72.8% from $777,000 a year earlier and up 148.7% from the prior quarter.

Analysis

Gossamer Bio (GOSS) Other Accumulated Expenses (2018 - 2020) Analysis & Trends

At the end of FY2019, Gossamer Bio reported Other Accumulated Expenses of $1.13 million, up 46.4% from FY2018.

  • Across earlier years, Other Accumulated Expenses came in at $769,000 in FY2018.
  • The Q2 2020 figure is the highest quarterly Other Accumulated Expenses since Q1 2019.
  • Per Business Quant, the preceding three quarters came in at $540,000 (Q1 2020), $1.13 million (Q4 2019) and $728,000 (Q3 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Gossamer Bio 38.40 Mn -435.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 529,000.00
Mar 31, 2020 540,000.00
Dec 31, 2019 1.13 Mn
Sep 30, 2019 728,000.00
Jun 30, 2019 777,000.00
Mar 31, 2019 1.86 Mn
Dec 31, 2018 769,000.00
API Access

Gossamer Bio Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GOSS&period=max&api_key=YOUR_API_KEY